Antibodies that bind to c-type lectin domain family 2 member d (CLEC2D)

The present disclosure relates to novel anti-CLEC2D antibodies and related compositions and methods of use thereof. These antibodies are used as therapeutics, and in prognostic and diagnostic applications in various cancers and other diseases.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Rao, Sahana Bhima, Markanda, Nikitha, Murugesan, Sathyabalan, Prachi, Natarajan, Bairavabalakumar, Lahiri, Pallavi, Dubey, Ashvini Kumar, Shenoy, Bharath Ravindra, Chakrabarty, Subhra Prakash, Halan, Vivek, Rodrigues, Kavitha Iyer, Muniraju, Yogendra Manjunath Bangalore, Tiwari, Anurag, Srivastava, Shruti, Sindhe, Kirthana Mysore Vasudevarao, Maity, Sunit, Bhattacharjee, Sanghamitra, Ramesh, Rao Shreesha, Dikey, Bhagyashree, Ghosh, Maloy
Format:	Patent
Sprache:	eng
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present disclosure relates to novel anti-CLEC2D antibodies and related compositions and methods of use thereof. These antibodies are used as therapeutics, and in prognostic and diagnostic applications in various cancers and other diseases.